High-risk patients with locally advanced non-small cell lung cancer treated with stereotactic body radiation therapy to the peripheral primary combined with conventionally fractionated volumetric arc…

RT @UKHD_radonc: Just out 🗞️ Eichkorn et al. (2023) on high-risk patients with locally advanced non-small cell lung cancer treated with SBR…

High-risk patients with locally advanced non-small cell lung cancer treated with stereotactic body radiation therapy to the peripheral primary combined with conventionally fractionated volumetric arc therapy to the mediastinal lymph nodes https://t.co/ukKl

Just out 🗞️ Eichkorn et al. (2023) on high-risk patients with locally advanced non-small cell lung cancer treated with SBRT to the peripheral primary combined with conventionally fractionated VMAT to the mediastinal lymph nodes. @uniklinik_hd @NCT_HD ht

New research: High-risk patients with locally advanced non-small cell lung cancer treated with stereotactic body radiation therapy to the peripheral primary combined with conventionally fractionated volumetric arc therapy to the mediastinal… https://t.co/S